Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDillistone Regulatory News (DSG)

Share Price Information for Dillistone (DSG)

Share Price is delayed by 15 minutes
Get Live Data
11.50    0.00 (0.00%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £4.07m
DSG Live PriceLast checked at - London Stock Exchange

Intraday Dillistone Share Chart

Issue of Options

27 Nov 2020 13:15

RNS Number : 7956G
Dillistone Group PLC
27 November 2020
 

 

Dillistone Group Plc

("Dillistone", the "Company" or the "Group")

Issue of Options

Dillistone Group Plc, the AIM quoted supplier of software for the international recruitment industry, announces the grant on 26 November 2020 of options over 353,000 Ordinary Shares of 5p each in Dillistone (the "Options") to certain of its Directors, a PDMR, and other members of staff under its HMRC approved Sharesave scheme at an exercise price of 14.4p.

Options over 97,500 Ordinary Shares were granted to four Directors and 1 PDMR as set out below.

 

Status

Sharesave option grant at 14.4p

No. Options held post Grant including LTIP

Current Shareholding in Company

Julie Pomeroy

Director

16,250

43,146

63,733

Alex James

Director

16,250

36,250

112,744

Simon Warburton

Director

16,250

100,646

77,290

Paul Mather

Director

32,500

156,292*

32,177

Steve Hammond

PDMR

16,250

93,146

-

Total

 

97,500

429,480

285,944

* Paul Mather's interest includes options over 58,146 shares granted to his spouse as an employee, 16,250 of which were granted yesterday.

Following this grant, the Company has 1,378,233 Ordinary Shares under option, representing c.7.01% of the current issued share capital of the Company.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Enquiries:

Dillistone Group Plc

 

 Via Walbrook PR

Jason Starr

Chief Executive

 

Julie Pomeroy

Finance Director

 

 

 

 

WH Ireland Limited (Nominated adviser)

 

 

Chris Fielding

Managing Director,

Corporate Finance

020 7220 1650

 

 

 

Walbrook PR

 

 

Tom Cooper / Nick Rome

 

020 7933 8780

 

 

dillistone@walbrookpr.com

 

Notes to Editors:

Dillistone Group Plc is a leader in the supply and support of software and services to the recruitment industry. Dillistone operates through the Ikiru People brand.

The Group develops, markets and supports the FileFinder, Infinity, Midoffice, ISV and GatedTalent products.

Dillistone was admitted to AIM, a market operated by the London Stock Exchange plc, in June 2006. The Group employs around 100 people globally with offices in Basingstoke, Southampton, New Jersey and Sydney.

 

Recruitment Software: https://www.voyagersoftware.com/recruitment-software-blog/best-recruitment-software-agencies/

GatedTalent Executive Search: https://www.talentis.global

FileFinder: https://www.dillistone.com

Temporary Recruitment Software: https://www.voyagersoftware.com/temporary-recruitment-agency-software/

ISV Skills Testing: https://www.isv.online

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

1) Julie Pomeroy

2) Alex James

3) Simon Warburton

4) Paul Mather

5) Steve Hammond

2.

Reason for the notification

a)

Position/status:

1) Group Finance Director

2) Chief Product Officer

3) Group Chief Technology Officer

4) Group Chief Operating Officer

5) PDMR

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Dillistone Group Plc

b)

LEI:

213800E9K3JGQ46ZS753

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Options over Ordinary shares of 5 pence each

 

ISIN Code: GB00B13QQB40

b)

Nature of the transaction:

 Grant of Options

c)

Price(s) and volume(s):

Price(s)

Volume(s)

1) 14.4 p

2) 14.4p

3) 14.4p

4) 14.4p

5) 14.4p

16,250

16,250

16,250

32,500

16,250

 

d)

Aggregated information:

· Aggregated volume:

· Price:

N/A

e)

Date of the transaction:

26 November 2020

f)

Place of the transaction:

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBXBDBLGDDGGR
Date   Source Headline
7th May 20267:00 amRNSFinal Results & Investor Presentation
24th Apr 20267:00 amRNSNotice of Final Results & Investor Presentation
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
2nd Mar 20263:08 pmRNSHolding(s) in Company
25th Feb 202611:40 amRNSHolding(s) in Company
25th Feb 202610:09 amRNSHolding(s) in Company
23rd Feb 20262:28 pmRNSResult of GM & Directorate Change
11th Feb 202612:59 pmRNSHolding(s) in Company
5th Feb 202611:28 amRNSResult of Placing and Subscription
4th Feb 20264:47 pmRNSProposed Placing and Subscription
30th Sep 20257:00 amRNSInterim Results & Investor Presentation
11th Sep 20257:00 amRNSNotice of Interim Results & Investor Presentation
4th Jun 202511:50 amRNSResult of AGM
4th Jun 20257:01 amRNSAGM Statement
4th Jun 20257:00 amRNSRelated party loan
9th May 202511:32 amRNSDirectorate Declaration
8th Apr 20257:00 amRNSFinal Results & Investor Presentation
3rd Apr 20257:00 amRNSNotice of Results & Investor Presentation
5th Feb 20257:00 amRNSTrading Update & Notice of Results
4th Dec 20247:00 amRNS-ROpenAI powered Interview Simulation Platform
17th Sep 20247:00 amRNSInterim Results & Investor Presentation
11th Sep 20247:00 amRNSNotice of Results & Investor Presentation
2nd Sep 20249:45 amRNSHolding(s) in Company
29th Aug 20248:30 amRNSHolding(s) in Company
23rd Aug 20247:00 amRNSTrading update and Fund Raising
15th Jul 20247:00 amRNSChange of Adviser
12th Jun 20241:40 pmRNSResult of AGM
12th Jun 20247:00 amRNSAGM Statement
25th Apr 20247:00 amRNSFinal Results & Investor Presentation
22nd Apr 20247:00 amRNSNotice of Results & Investor Presentation
9th Apr 20247:00 amRNSBlock listing Interim Review
30th Jan 20247:00 amRNSTrading Update & Notice of Results
9th Oct 20237:00 amRNSBlock listing Interim Review
26th Sep 20237:00 amRNSInterim Results & Investor Presentations
18th Sep 20237:00 amRNSNotice of Results & Investor Presentations
13th Jun 20231:18 pmRNSResult of AGM
13th Jun 20237:00 amRNSAGM Statement
25th Apr 20237:00 amRNSFinal Results & Investor Presentation
11th Apr 20237:00 amRNSBlock listing Interim Review
30th Mar 20237:00 amRNSContract & Notice of Results
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
7th Nov 20227:00 amRNSDirector Dealings
10th Oct 20227:00 amRNSBlock listing Interim Review
26th Sep 20227:01 amRNSDirectorate Changes
26th Sep 20227:00 amRNSInterim Results & Investor Presentation
20th Sep 20227:00 amRNSNotice of Results & Investor Presentation
16th Jun 20228:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.